Richard Elgen, Zach Pitluk | GenomeWeb

Richard Elgen has joined PerkinElmer as vice president and general manager of discovery and research reagents for the firm's Life and Analytical Sciences unit. Elgen joins PerkinElmer from DiscoveRx, where he served as chief scientific officer and executive vice president for research and development.

He holds a PhD in molecular pharmacology from Trent University in Nottingham, UK.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.